Kevin Ho
InvestorDirector, Business Development & Acquisitions at AbbVie
San Francisco Bay Area
Writes $100K – $5M checks · typically $1.5M
Find your path to Kevin
395 people in our graph share verified history with Kevin — schools, employers, funds. One of them is your warm intro.
Richard SimoniunlockedKevin: together at Asset Management Ventures (2020–2021)
×4Kevin: together at Gates Ventures
×3Kevin: together at Devoted Health
×4Kevin: together at Clinton Health Access Initiative
About
Kevin Ho is Director of Business Development & Acquisitions at AbbVie. He works in pharmaceutical development and acquisition strategy, bringing a non-scientific background to the role.
Experience
- AbbVieDirector, Business Development & Acquisitionscurrent2025 — presentSouth San Francisco, California, United States
- AbbVieAssociate Director, Business Development & Acquisitions2024 — 2025South San Francisco, California, United States
- Gilead SciencesAssociate Director, Corporate Strategy and Projects, CEO Office2023 — 2024Foster City, California, United States
- Gilead SciencesSenior Manager, Corporate Development2022 — 2023Foster City, California, United States
- Devoted HealthMBA Intern2021
- Asset Management VenturesAssociate2020 — 2021San Francisco Bay Area
- GenentechPipeline, Planning, and Portfolio2020South San Francisco, California, United States
- Gates VenturesManager, Health and Life Sciences2017 — 2020Greater Seattle Area
- Clinton Health Access InitiativeSenior Associate, Vaccine Market Access2015 — 2017San Francisco Bay Area
- Bain & CompanyAssociate Consultant2013 — 2015San Francisco Bay Area
- VestergaardPublic Health Associate2012Nairobi, Kenya
- Bain & CompanyAssociate Consultant Intern2011San Francisco Bay Area
Skills & more
Management9Strategy3Public Speaking6Leadership7Research4Data Analysis3Social Media3Recruiting6Start-ups3Marketing1Nonprofits1Excel3
+5 more
PowerPointSASMicrosoft ExcelMicrosoft OfficeProcess ImprovementLanguages Chinese · English · Spanish
From Kevin's professional profile.
Colleagues at AbbVie
Anke Reichardt
Investor at AbbVie
Azurii Collier
Commercial Advisor at 2Flo Ventures
Christian Schubert
Head of AbbVie Ventures at AbbVie
Christina Vorvis
Director at AbbVie
Claire Leurent
Managing Director at AbbVie
Donmienne Leung
Director II, Head of AbbVie Ventures Europe at AbbVie
Doug Faunce
Executive Director at AbbVie
Joachim Vogt
Director at AbbVie
Frequently asked questions
- Who is Kevin Ho?
- Kevin Ho is Director of Business Development & Acquisitions at AbbVie. He works in pharmaceutical development and acquisition strategy, bringing a non-scientific background to the role.
- Where does Kevin Ho work?
- Kevin Ho is Director, Business Development & Acquisitions at AbbVie.
- What check size does Kevin Ho write?
- Kevin Ho typically writes checks of $100K – $5M.
- Where did Kevin Ho go to school?
- Kevin Ho studied at Stanford University Graduate School of Business (Master of Business Administration - MBA); Yale University (Master of Public Health (MPH), Health Policy and Administration); Yale University (BA, Ethics).
Same school
Also attended Stanford University Graduate School of Business2,000
Roelof BothaAdvisor & former Steward at Sequoia Capital; SpaceX board memberPeter FentonGeneral Partner at BenchmarkSteve JurvetsonCo-founder of Future VenturesDavid SzeAdvisory Partner at GreylockKatherine BoyleGeneral Partner at Andreessen Horowitz (American Dynamism)Hunter WalkCo-founder & Partner at Homebrew
+ 1,994 more
Also attended Yale University1,087
Ann Miura-KoCo-founding Partner at FloodgateDavid SzeAdvisory Partner at GreylockMichael SeibelPartner Emeritus at Y CombinatorBen SilbermannCo-founder of PinterestZheela QaiserInvestor at Index VenturesAnthony PhilippakisInvestor at GV (Google Ventures)
+ 1,081 more
Shared employers
Also worked at AbbVie66
Nick GasbarroChief of Staff at QED InvestorsCharles White, Ph.D.Principal at Illumina VenturesLaura QuockCBO-in-Residence at Versant VenturesManik PasrichaVice President at Titan CapitalJennifer SmoterChief Communications & Governance Officer at Takeda VenturesTakehiko SawabeDirector at Beyond Next Ventures
+ 60 more
Also worked at Gilead Sciences55
Uri LopatinInvestor at Khosla VenturesJay ParrishVenture Partner at ARCH Venture PartnersPatrick LoerchBio Advisor at Amplify PartnersLaura QuockCBO-in-Residence at Versant VenturesLan WuAnalyst at FusionAriel RahamimAn investor in pre-seed and idea stage startups
+ 49 more
Also worked at Genentech249
David SchenkeinInvestor at GV (Google Ventures)Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Marco PrunottoInvestor at MedicxiLogan HilleLife Sciences Analyst at CincyTechJosephine ChenInvestor at Sequoia CapitalAbbie CelnikerInvestor at Third Rock Ventures
+ 243 more
Also worked at Gates Ventures8
Aishu SukumarAlzheimer's Moonshot Impact Board at StartUp HealthOliver RothschildManaging Director at The Draper Richards Kaplan FoundationAlex ReidChief Communications Officer at Bill & Melinda Gates FoundationRodi GuideroExecutive Director, Breakthrough Energy; Managing Partner, Breakthrough Energy Ventures at Breakthrough Energy VenturesQuinn CorneliusBreakthrough Energy Ventures at Breakthrough Energy VenturesBen GaddyBreakthrough Energy Discovery at Breakthrough Energy Ventures
+ 2 more

















































